Medicine and Dentistry
Limb Perfusion
100%
Soft Tissue Sarcoma
91%
Neoplasm
72%
Tumor Necrosis Factor
66%
Melphalan
58%
Hyperthermic Intraperitoneal Chemotherapy
51%
Recurrent Disease
50%
Cytoreductive Surgery
49%
Nodular Melanoma
49%
Surgery
45%
Peritoneum Metastasis
33%
Retroperitoneal Lymph Node Dissection
31%
Disease
27%
Positron Emission Tomography
25%
Limb Salvage
21%
External Beam Radiotherapy
19%
Overall Survival
19%
Sarcoma
19%
Sentinel Lymph Node Biopsy
19%
Malignant Neoplasm
16%
Distant Metastasis
15%
Laparoscopy
15%
Disease Free Survival
14%
Diagnosis
14%
Radiation Therapy
14%
Adjuvant Radiotherapy
14%
Limb
13%
Cutaneous Melanoma
12%
Sentinel Node
12%
Carcinomatous Peritonitis
12%
Cancer
12%
Wound Complication
11%
Peritoneum Cancer
11%
Colorectal Cancer
11%
Surgeon
11%
Inguinal Lymph Node
11%
Necrosis
11%
Venous Ulcer
10%
Metastatic Carcinoma
10%
Prognostic Factor
10%
Axilla
10%
Quality of Life
10%
Amputation
10%
Lymph Node Metastasis
9%
Drug Megadose
9%
Fluorodeoxyglucose
9%
Positron Emission Tomography
8%
Retroperitoneal Tumor
8%
Gamma Interferon
8%
Symptom
8%
Keyphrases
Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
37%
Colorectal Peritoneal Metastases
26%
Isolated Limb Perfusion
22%
Melphalan
19%
Cytoreductive Surgery
17%
Extremity Soft Tissue Sarcoma
17%
Hyperthermic Isolated Limb Perfusion
17%
Tumor Necrosis Factor-α
16%
Local Recurrence
13%
Diagnostic Laparoscopy
13%
Soft Tissue Sarcoma
12%
Radiotherapy
12%
Overall Survival
11%
Peritoneal Cancer Index
11%
Perfusion
10%
Melanoma
9%
Computed Tomography
9%
Health Care Costs
8%
Selection Tool
8%
Advanced Soft Tissue Sarcoma
7%
Distant Metastasis
6%
Locally Advanced
5%
Survival Outcomes
5%
Cisplatin
5%
Peritoneal Metastasis
5%
Metastasis
5%
Treatment-related
5%
Melanoma Patients
5%
